1,491 Shares in UnitedHealth Group Incorporated (NYSE:UNH) Purchased by Antonelli Financial Advisors LLC

Antonelli Financial Advisors LLC bought a new stake in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund bought 1,491 shares of the healthcare conglomerate's stock, valued at approximately $754,000. UnitedHealth Group accounts for approximately 0.6% of Antonelli Financial Advisors LLC's portfolio, making the stock its 26th biggest position.

A number of other hedge funds have also recently added to or reduced their stakes in the company. NewSquare Capital LLC purchased a new position in shares of UnitedHealth Group in the 4th quarter worth $25,000. AlphaMark Advisors LLC acquired a new stake in shares of UnitedHealth Group in the fourth quarter worth $30,000. Promus Capital LLC acquired a new stake in UnitedHealth Group in the 4th quarter valued at $32,000. RPg Family Wealth Advisory LLC acquired a new position in shares of UnitedHealth Group during the third quarter worth about $37,000. Finally, Pillar Financial Advisors LLC acquired a new stake in shares of UnitedHealth Group in the fourth quarter valued at about $40,000. Institutional investors and hedge funds own 87.86% of the company's stock.

UnitedHealth Group Stock Performance

Shares of NYSE:UNH traded down $2.92 during midday trading on Tuesday, hitting $513.58. The company's stock had a trading volume of 3,014,727 shares, compared to its average volume of 4,086,166. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $630.73. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. The stock has a market capitalization of $469.78 billion, a price-to-earnings ratio of 33.13, a PEG ratio of 1.37 and a beta of 0.62. The stock's 50 day simple moving average is $509.71 and its 200 day simple moving average is $546.15.

Remove Ads

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The company had revenue of $100.81 billion for the quarter, compared to analyst estimates of $101.60 billion. During the same period last year, the business posted $5.83 EPS. The business's quarterly revenue was up 6.8% on a year-over-year basis. As a group, research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th were paid a dividend of $2.10 per share. The ex-dividend date was Monday, March 10th. This represents a $8.40 annualized dividend and a yield of 1.64%. UnitedHealth Group's dividend payout ratio is 54.19%.

Analysts Set New Price Targets

A number of equities analysts have issued reports on the company. Piper Sandler cut their target price on UnitedHealth Group from $605.00 to $600.00 and set an "overweight" rating on the stock in a research report on Thursday, January 2nd. Barclays dropped their target price on shares of UnitedHealth Group from $655.00 to $642.00 and set an "overweight" rating for the company in a research report on Friday, January 17th. HSBC raised UnitedHealth Group from a "hold" rating to a "buy" rating and set a $595.00 target price on the stock in a report on Friday, January 10th. Stephens upped their price target on UnitedHealth Group from $605.00 to $675.00 and gave the company an "overweight" rating in a research report on Thursday, December 5th. Finally, Truist Financial dropped their target price on shares of UnitedHealth Group from $625.00 to $610.00 and set a "buy" rating on the stock in a report on Monday, January 6th. Twenty equities research analysts have rated the stock with a buy rating and two have issued a strong buy rating to the stock. According to data from MarketBeat.com, the stock has an average rating of "Buy" and an average target price of $629.32.

Insider Buying and Selling

In other news, Director Timothy Patrick Flynn purchased 1,000 shares of the firm's stock in a transaction dated Friday, January 17th. The stock was bought at an average price of $511.57 per share, with a total value of $511,570.00. Following the acquisition, the director now directly owns 4,500 shares of the company's stock, valued at approximately $2,302,065. This represents a 28.57 % increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. 0.33% of the stock is owned by corporate insiders.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.